Navigation Links
ICSI or IVF: Babies born from frozen embryos do just as well
Date:6/29/2009

Amsterdam, The Netherlands: Analysis of the longest running ICSI programme in the United States has found reassuring evidence that babies born from frozen embryos fertilised via ICSI (intracytoplasmic sperm injection) do just as well as those born from frozen embryos fertilised via standard IVF treatment.

The researchers also compared babies born as a result of cycles in which the women had additional hormone medication with babies born as a result of unmedicated, natural cycles, and, although they found a slightly higher rate of malformations in babies born from medicated cycles, the difference was small 2.2% versus 0.4%.

Ms Queenie Neri, a research associate at Cornell University (New York, USA) and a member of the team headed by Professor Gianpiero Palermo who pioneered ICSI in 1992, told the 25th annual meeting of the European Society of Human Reproduction and Embryology in Amsterdam today (Monday) that she and her colleagues had looked at all births from frozen embryos, conceived via ICSI or IVF, between 1993 and 2007.

Ms Neri identified 720 IVF and 1231 ICSI frozen embryo transfers. The survival rate of the frozen embryos was 74% after IVF and 77.2% after ICSI. The clinical pregnancy rate was 42.8% after IVF and 39.4% after ICSI. These resulted in 84.1% IVF and 89.7% ICSI deliveries. There were 27.8% multiple IVF pregnancies and 21.1% multiple ICSI pregnancies. Outcomes at the time of birth for Apgar scores, gestational ages, birth weights and congenital malformations were similar for both IVF and ICSI singleton babies.

When she grouped the babies according to whether they came from medicated or unmedicated cycles, she found that the clinical pregnancy rate was 42.1% and 39.4% respectively; delivery rates were 86.7% (with 28.7% multiple births) and 87.5% (19.2% multiple births) respectively. Gestational ages and birth weights were similar between the two groups, but the malformation rate was 2.2% from the medicated cyc
'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
European Society for Human Reproduction and Embryology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Babies born to native high-altitude mothers have decreased risk of low birth weight
2. Tufted bacteria cause infection in premature babies
3. Engineering bouncing babies, 1 at a time
4. Mama whales teach babies where to eat
5. Study finds rescue course of antenatal steroids improves outcome in premature babies
6. Consumers desire more genetic testing, but not designer babies
7. World breakthrough in treating premature babies
8. Virus weaves itself into the DNA transferred from parents to babies
9. Codeine not safe for all breastfeeding moms and their babies
10. Embryo biopsy does not affect early growth and risk of congenital malformations in PGD/PGS babies
11. Too much or too little weight gain poses risks to pregnant mothers, babies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... at last worked out a way of using recordings of b...ulations. This is the first time sound recordings ...accurate estimates of bird species, populations. B...Ecological Society,s Journal of Applied Ecology ,...a major advance in our ability to monitor whale an...
(Date:11/26/2009)...in-resistant Staphylococcus Aureus ) and other dr...ow-temperature plasma prototype devices have been ... bactericidal cocktails. , Two prototype devices...on of healthy skin (e.g. hands and feet) in hospit...thal threat; and another to shoot bacteria-killing...
(Date:11/25/2009)..., firefighters, police officers and ambulance work...Trade Center complex. They battled to save people ...ivors, tackled fires and evacuated as many people ...ted 17,000 people. And making their jobs even hard...ned workers and their relatives jammed mobile netw...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Frost 26amp 3B Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low Dose Contraceptive Patch 14508 1Frost 26amp 3B Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low Dose Contraceptive Patch 14508 2Frost 26amp 3B Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low Dose Contraceptive Patch 14508 3Frost 26amp 3B Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low Dose Contraceptive Patch 14508 4Frost 26amp 3B Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low Dose Contraceptive Patch 14508 5Grifols Breaks Ground on New National Testing Laboratory 14506 1Grifols Breaks Ground on New National Testing Laboratory 14506 2U S Food and Drug Administration Approves CRESTOR 28R 29 for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia 5525 1U S Food and Drug Administration Approves CRESTOR 28R 29 for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia 5525 2U S Food and Drug Administration Approves CRESTOR 28R 29 for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia 5525 3U S Food and Drug Administration Approves CRESTOR 28R 29 for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia 5525 4
...l be brought to the marketplace, giving laboratori... organisms. EMBLEM Technology Transfer GmbH (EMBLE...r Biology Laboratory (EMBL), announced today that ...leader Carl Zeiss to commercialize a new technolog...copy). , "Microscopes have to evolve to keep up wi...
...of Reproduction contains a report of some intrigui...i from one genus of fish were transplanted to enuc... offspring, cloned from nuclei of common carp and ...l to the nuclear donor species, Cyprinus carpio, i...er of vertebrae in the clones, however, was in the...
...nce and drug development : only "lucrative","marke...casions I,ve,seen very promising drugs candidates ...s to be made with it, even if millions would have,...this fate is to find,a drug candidate that affect ...fitable" one. PLoS Medecine has an article about a...
Other Biology News:The transparent organism: EMBLEM and Carl Zeiss give labs a unique look at life 2Finding Cures For Tropical Diseases: Is Open Source An Answer? 2
(Date:11/24/2009)...24 Sigma-Aldrich Corpora...SDAQ OMX conference on Tuesday, December 1st at 1:...rties may listen via live audio broadcast over the...m a a ldrich.com/ . Users can click the "Webc...ma-Aldrich: Sigma-Aldrich is a leading Life Scie...
(Date:11/24/2009)...YKJAVIK, Iceland, November 24 /PRNewswire-FirstCal...announced the approval of all of its,"first day" m...ct of Delaware,(the "Bankruptcy Court"). deCODE la...r Chapter 11 of the United States Bankruptcy Code ...ssued by the Bankruptcy Court allow the company to...
(Date:11/24/2009)...f., Nov. 24 NeurogesX, I...focused on developing and commercializing novel pa...ony DiTonno, President and Chief Executive Officer... Jaffray Health Care Conference, to be held Decemb...ork, New York. ,, Mr. DiTonno and Stephen Ghig...
(Date:11/24/2009)...RNewswire/ -- Blue Marble Energy Corp. announced t...pment Authority (OPDA) were recently awarded $2 mi...italization Board (CERB) in a private/public partn...ochemical biorefinery in Lincoln County, WA. ,...evelopment of our biorefinery and bring over 70 gr...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
...ust 28 Strong organic,growth continued in Q2 2008...development of Exiqon,s first molecular diagnostic... for year end launch., - Revenue in Q2 2008 incr...8 million, totaling DKK 44.5 million in the first ...ncreased by 239% on the same period last year to ...
...olcano Corporation,(Nasdaq: VOLC ), a leading man...d (IVUS), functional measurement (FM) and Optical ...hance the diagnosis and treatment,of coronary and ...ll be,participating in the Thomas Weisel Partners ...4., The presentation by Scott Huennekens, preside...
...ance, August 28 , - Hubert Sagnieres Appointed Ch...rectors of Essilor International today appointed H...ve alongside Xavier Fontanet,Chief Executive Offic..., A graduate of Ecole Centrale in Lille and holde...silor in 1989 as President of International,Market...
Other Biology Technology:Exiqon A/S: Interim Report for the Period 1 January - 30 June 2008 (Unaudited) 2Volcano Presentation at Thomas Weisel Conference to Be Webcast 2
...reedom EVOlyzer is Tecans new Enzyme-Linked Immuno...mated microplate processing. Freedom EVOlyzer is a...ng and includes state-of-the art reader, washer an...ed EVOlyzer software. The Freedom EVOlyzer is avai...
...ins are polypeptide hormones which belong to the t... TGF- superfamily is a large group of extra-cellul...velopment, reproductive function and tumor formati...etic proteins, growth differentiation factors, AMH...
...read Plating Beads Sterile plating in just secon...rdous ethanol flaming, More uniform spreading and...le packaging: dispenser bottle for spreading 100 p...t and easiest way to spread cells on multiple plat...
...aboratories working in a regulated environment, Pi...software that automates gravimetric pipette calibr...eets todays regulatory compliance requirements. Pi...es a full security implementation, support for Ora...
Biology Products: